0

Close
 
Upcoming Allied Market Research
2023
Urinalysis Market

Urinalysis Market

by Product (Dipstick, Reagent, Urine Analyser, POC), by Test Type (Biochemical, Sediment, Microscopic), by Application (Diagnosis, Diabetes, UTI, Kidney Disease, Pregnancy) and by End User (Hospital, Research Institute, Home): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A00901
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Urinalysis Market

Request Now !

Urinalysis is a test conducted for analysis of urine sample, and assists in detecting wide range of disorders, such as diabetes, kidney disease, and urinary tract infection. Its primary aim is to monitor health conditions. The urinalysis is carried out as routine medical check-up, pre-surgery preparation, pregnancy check-up, or on hospital admission to treat various disorders. It also helps to identify the cause of the symptoms, such as back pain, abdominal pain, and painful urination.

The rising prevalence of kidney diseases, implementation of PPACA and increase in geriatric population are factor propelling the growth of the world urinalysis market. However, implementation of excise tax by the U.S. government and stringent regulatory procedures are factors hindering the growth of the market. Integrated systems & urinalysis via smartphones and technological advancement present opportunities in the market.

The world urinalysis market is segmented based on product, test type, application, end user, and geography. The product segment is further classified based on dipstick, reagent, urine analyzer, and POC. The test types discussed in the report are biochemical, sediment, and microscopic. The applications covered in the report include diagnosis, diabetes, UTI, kidney disease, and pregnancy. The end users included in the report are home, hospitals, and research institutes. Geographically, the market is segmented based on North America, Europe, Asia-Pacific, and Latin America, Middle East and Africa (LAMEA).

The prominent companies operating in the market are Arkray Inc., Beckman Coulter Inc., Roche Diagnostics, Siemens Healthcare, Sysmex Corporation, Elektronika KFT., Acon Laboratories Inc., Bio-Rad Laboratories Inc., Mindray Medical International Limited, and URIT Medical Electronic Group Co. Ltd. They have adopted strategies, such as mergers & acquisitions, partnerships, collaborations, expansions, agreements, new product launches, joint ventures, and others to strengthen their position in the market.

KEY BENEFITS FOR STAKEHOLDERS:

  • The report offers a detailed analysis of key driving and restraining factors of the world urinalysis market.
  • This report offers an in-depth quantitative analysis of the current market and estimations which assists in identifying the prevailing market opportunities.
  • An exhaustive analysis of key strategies adopted by leading manufacturers helps in understanding competitive scenario.
  • The report provides an extensive analysis of current and future market status of the world urinalysis market.
  • Comprehensive analysis has been done in this report by constructing market estimations for the key market segments.
  • An extensive analysis of current research and clinical developments within the world urinalysis market is provided with key market dynamic factors that help in understanding the behavior of the market.
  • The world urinalysis market is segmented into North America, Asia-Pacific, Europe, and Latin America, Middle East and Africa (LAMEA).

 Urinalysis Market Report Highlights

Aspects Details
By Product
  • Dipstick
  • Reagent
  • Urine Analyser
  • POC
By Test Type
  • Biochemical
  • Sediment
  • Microscopic
By Application
  • Diagnosis
  • Diabetes
  • UTI
  • Kidney Disease
  • Pregnancy
By End User
  • Hospital
  • Research Institute
  • Home
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Rest of LAMEA)
Key Market Players Arkray Inc., Sysmex Corporation, Mindray Medical International Limited, Bio-Rad Laboratories Inc., Roche Diagnostics, Elektronika KFT, Acon Laboratories Inc., URIT Medical Electronic Group Co. Ltd., Beckman Coulter Inc., Siemens Healthcare
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: URINALYSIS MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. Dipstick

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Reagent

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Urine Analyser

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. POC

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: URINALYSIS MARKET, BY TEST TYPE

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Test Type

    • 5.2. Biochemical

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Sediment

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Microscopic

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

  • CHAPTER 6: URINALYSIS MARKET, BY APPLICATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Application

    • 6.2. Diagnosis

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Diabetes

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. UTI

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Kidney Disease

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Pregnancy

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

  • CHAPTER 7: URINALYSIS MARKET, BY END USER

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By End User

    • 7.2. Hospital

      • 7.2.1. Key Market Trends, Growth Factors and Opportunities

      • 7.2.2. Market Size and Forecast, By Region

      • 7.2.3. Market Share Analysis, By Country

    • 7.3. Research Institute

      • 7.3.1. Key Market Trends, Growth Factors and Opportunities

      • 7.3.2. Market Size and Forecast, By Region

      • 7.3.3. Market Share Analysis, By Country

    • 7.4. Home

      • 7.4.1. Key Market Trends, Growth Factors and Opportunities

      • 7.4.2. Market Size and Forecast, By Region

      • 7.4.3. Market Share Analysis, By Country

  • CHAPTER 8: URINALYSIS MARKET, BY REGION

    • 8.1. Market Overview

      • 8.1.1 Market Size and Forecast, By Region

    • 8.2. North America

      • 8.2.1. Key Market Trends and Opportunities

      • 8.2.2. Market Size and Forecast, By Product

      • 8.2.3. Market Size and Forecast, By Test Type

      • 8.2.4. Market Size and Forecast, By Application

      • 8.2.5. Market Size and Forecast, By End User

      • 8.2.6. Market Size and Forecast, By Country

      • 8.2.7. U.S. Urinalysis Market

        • 8.2.7.1. Market Size and Forecast, By Product
        • 8.2.7.2. Market Size and Forecast, By Test Type
        • 8.2.7.3. Market Size and Forecast, By Application
        • 8.2.7.4. Market Size and Forecast, By End User

      • 8.2.8. Canada Urinalysis Market

        • 8.2.8.1. Market Size and Forecast, By Product
        • 8.2.8.2. Market Size and Forecast, By Test Type
        • 8.2.8.3. Market Size and Forecast, By Application
        • 8.2.8.4. Market Size and Forecast, By End User

      • 8.2.9. Mexico Urinalysis Market

        • 8.2.9.1. Market Size and Forecast, By Product
        • 8.2.9.2. Market Size and Forecast, By Test Type
        • 8.2.9.3. Market Size and Forecast, By Application
        • 8.2.9.4. Market Size and Forecast, By End User

    • 8.3. Europe

      • 8.3.1. Key Market Trends and Opportunities

      • 8.3.2. Market Size and Forecast, By Product

      • 8.3.3. Market Size and Forecast, By Test Type

      • 8.3.4. Market Size and Forecast, By Application

      • 8.3.5. Market Size and Forecast, By End User

      • 8.3.6. Market Size and Forecast, By Country

      • 8.3.7. France Urinalysis Market

        • 8.3.7.1. Market Size and Forecast, By Product
        • 8.3.7.2. Market Size and Forecast, By Test Type
        • 8.3.7.3. Market Size and Forecast, By Application
        • 8.3.7.4. Market Size and Forecast, By End User

      • 8.3.8. Germany Urinalysis Market

        • 8.3.8.1. Market Size and Forecast, By Product
        • 8.3.8.2. Market Size and Forecast, By Test Type
        • 8.3.8.3. Market Size and Forecast, By Application
        • 8.3.8.4. Market Size and Forecast, By End User

      • 8.3.9. Italy Urinalysis Market

        • 8.3.9.1. Market Size and Forecast, By Product
        • 8.3.9.2. Market Size and Forecast, By Test Type
        • 8.3.9.3. Market Size and Forecast, By Application
        • 8.3.9.4. Market Size and Forecast, By End User

      • 8.3.10. Spain Urinalysis Market

        • 8.3.10.1. Market Size and Forecast, By Product
        • 8.3.10.2. Market Size and Forecast, By Test Type
        • 8.3.10.3. Market Size and Forecast, By Application
        • 8.3.10.4. Market Size and Forecast, By End User

      • 8.3.11. UK Urinalysis Market

        • 8.3.11.1. Market Size and Forecast, By Product
        • 8.3.11.2. Market Size and Forecast, By Test Type
        • 8.3.11.3. Market Size and Forecast, By Application
        • 8.3.11.4. Market Size and Forecast, By End User

      • 8.3.12. Russia Urinalysis Market

        • 8.3.12.1. Market Size and Forecast, By Product
        • 8.3.12.2. Market Size and Forecast, By Test Type
        • 8.3.12.3. Market Size and Forecast, By Application
        • 8.3.12.4. Market Size and Forecast, By End User

      • 8.3.13. Rest Of Europe Urinalysis Market

        • 8.3.13.1. Market Size and Forecast, By Product
        • 8.3.13.2. Market Size and Forecast, By Test Type
        • 8.3.13.3. Market Size and Forecast, By Application
        • 8.3.13.4. Market Size and Forecast, By End User

    • 8.4. Asia-Pacific

      • 8.4.1. Key Market Trends and Opportunities

      • 8.4.2. Market Size and Forecast, By Product

      • 8.4.3. Market Size and Forecast, By Test Type

      • 8.4.4. Market Size and Forecast, By Application

      • 8.4.5. Market Size and Forecast, By End User

      • 8.4.6. Market Size and Forecast, By Country

      • 8.4.7. China Urinalysis Market

        • 8.4.7.1. Market Size and Forecast, By Product
        • 8.4.7.2. Market Size and Forecast, By Test Type
        • 8.4.7.3. Market Size and Forecast, By Application
        • 8.4.7.4. Market Size and Forecast, By End User

      • 8.4.8. Japan Urinalysis Market

        • 8.4.8.1. Market Size and Forecast, By Product
        • 8.4.8.2. Market Size and Forecast, By Test Type
        • 8.4.8.3. Market Size and Forecast, By Application
        • 8.4.8.4. Market Size and Forecast, By End User

      • 8.4.9. India Urinalysis Market

        • 8.4.9.1. Market Size and Forecast, By Product
        • 8.4.9.2. Market Size and Forecast, By Test Type
        • 8.4.9.3. Market Size and Forecast, By Application
        • 8.4.9.4. Market Size and Forecast, By End User

      • 8.4.10. South Korea Urinalysis Market

        • 8.4.10.1. Market Size and Forecast, By Product
        • 8.4.10.2. Market Size and Forecast, By Test Type
        • 8.4.10.3. Market Size and Forecast, By Application
        • 8.4.10.4. Market Size and Forecast, By End User

      • 8.4.11. Australia Urinalysis Market

        • 8.4.11.1. Market Size and Forecast, By Product
        • 8.4.11.2. Market Size and Forecast, By Test Type
        • 8.4.11.3. Market Size and Forecast, By Application
        • 8.4.11.4. Market Size and Forecast, By End User

      • 8.4.12. Thailand Urinalysis Market

        • 8.4.12.1. Market Size and Forecast, By Product
        • 8.4.12.2. Market Size and Forecast, By Test Type
        • 8.4.12.3. Market Size and Forecast, By Application
        • 8.4.12.4. Market Size and Forecast, By End User

      • 8.4.13. Malaysia Urinalysis Market

        • 8.4.13.1. Market Size and Forecast, By Product
        • 8.4.13.2. Market Size and Forecast, By Test Type
        • 8.4.13.3. Market Size and Forecast, By Application
        • 8.4.13.4. Market Size and Forecast, By End User

      • 8.4.14. Indonesia Urinalysis Market

        • 8.4.14.1. Market Size and Forecast, By Product
        • 8.4.14.2. Market Size and Forecast, By Test Type
        • 8.4.14.3. Market Size and Forecast, By Application
        • 8.4.14.4. Market Size and Forecast, By End User

      • 8.4.15. Rest of Asia Pacific Urinalysis Market

        • 8.4.15.1. Market Size and Forecast, By Product
        • 8.4.15.2. Market Size and Forecast, By Test Type
        • 8.4.15.3. Market Size and Forecast, By Application
        • 8.4.15.4. Market Size and Forecast, By End User

    • 8.5. LAMEA

      • 8.5.1. Key Market Trends and Opportunities

      • 8.5.2. Market Size and Forecast, By Product

      • 8.5.3. Market Size and Forecast, By Test Type

      • 8.5.4. Market Size and Forecast, By Application

      • 8.5.5. Market Size and Forecast, By End User

      • 8.5.6. Market Size and Forecast, By Country

      • 8.5.7. Brazil Urinalysis Market

        • 8.5.7.1. Market Size and Forecast, By Product
        • 8.5.7.2. Market Size and Forecast, By Test Type
        • 8.5.7.3. Market Size and Forecast, By Application
        • 8.5.7.4. Market Size and Forecast, By End User

      • 8.5.8. South Africa Urinalysis Market

        • 8.5.8.1. Market Size and Forecast, By Product
        • 8.5.8.2. Market Size and Forecast, By Test Type
        • 8.5.8.3. Market Size and Forecast, By Application
        • 8.5.8.4. Market Size and Forecast, By End User

      • 8.5.9. Saudi Arabia Urinalysis Market

        • 8.5.9.1. Market Size and Forecast, By Product
        • 8.5.9.2. Market Size and Forecast, By Test Type
        • 8.5.9.3. Market Size and Forecast, By Application
        • 8.5.9.4. Market Size and Forecast, By End User

      • 8.5.10. UAE Urinalysis Market

        • 8.5.10.1. Market Size and Forecast, By Product
        • 8.5.10.2. Market Size and Forecast, By Test Type
        • 8.5.10.3. Market Size and Forecast, By Application
        • 8.5.10.4. Market Size and Forecast, By End User

      • 8.5.11. Argentina Urinalysis Market

        • 8.5.11.1. Market Size and Forecast, By Product
        • 8.5.11.2. Market Size and Forecast, By Test Type
        • 8.5.11.3. Market Size and Forecast, By Application
        • 8.5.11.4. Market Size and Forecast, By End User

      • 8.5.12. Rest of LAMEA Urinalysis Market

        • 8.5.12.1. Market Size and Forecast, By Product
        • 8.5.12.2. Market Size and Forecast, By Test Type
        • 8.5.12.3. Market Size and Forecast, By Application
        • 8.5.12.4. Market Size and Forecast, By End User

  • CHAPTER 9: COMPETITIVE LANDSCAPE

    • 9.1. Introduction

    • 9.2. Top Winning Strategies

    • 9.3. Product Mapping Of Top 10 Player

    • 9.4. Competitive Dashboard

    • 9.5. Competitive Heatmap

    • 9.6. Top Player Positioning,2022

  • CHAPTER 10: COMPANY PROFILES

    • 10.1. Arkray Inc.

      • 10.1.1. Company Overview

      • 10.1.2. Key Executives

      • 10.1.3. Company Snapshot

      • 10.1.4. Operating Business Segments

      • 10.1.5. Product Portfolio

      • 10.1.6. Business Performance

      • 10.1.7. Key Strategic Moves and Developments

    • 10.2. Beckman Coulter Inc.

      • 10.2.1. Company Overview

      • 10.2.2. Key Executives

      • 10.2.3. Company Snapshot

      • 10.2.4. Operating Business Segments

      • 10.2.5. Product Portfolio

      • 10.2.6. Business Performance

      • 10.2.7. Key Strategic Moves and Developments

    • 10.3. Roche Diagnostics

      • 10.3.1. Company Overview

      • 10.3.2. Key Executives

      • 10.3.3. Company Snapshot

      • 10.3.4. Operating Business Segments

      • 10.3.5. Product Portfolio

      • 10.3.6. Business Performance

      • 10.3.7. Key Strategic Moves and Developments

    • 10.4. Siemens Healthcare

      • 10.4.1. Company Overview

      • 10.4.2. Key Executives

      • 10.4.3. Company Snapshot

      • 10.4.4. Operating Business Segments

      • 10.4.5. Product Portfolio

      • 10.4.6. Business Performance

      • 10.4.7. Key Strategic Moves and Developments

    • 10.5. Sysmex Corporation

      • 10.5.1. Company Overview

      • 10.5.2. Key Executives

      • 10.5.3. Company Snapshot

      • 10.5.4. Operating Business Segments

      • 10.5.5. Product Portfolio

      • 10.5.6. Business Performance

      • 10.5.7. Key Strategic Moves and Developments

    • 10.6. Elektronika KFT

      • 10.6.1. Company Overview

      • 10.6.2. Key Executives

      • 10.6.3. Company Snapshot

      • 10.6.4. Operating Business Segments

      • 10.6.5. Product Portfolio

      • 10.6.6. Business Performance

      • 10.6.7. Key Strategic Moves and Developments

    • 10.7. Acon Laboratories Inc.

      • 10.7.1. Company Overview

      • 10.7.2. Key Executives

      • 10.7.3. Company Snapshot

      • 10.7.4. Operating Business Segments

      • 10.7.5. Product Portfolio

      • 10.7.6. Business Performance

      • 10.7.7. Key Strategic Moves and Developments

    • 10.8. Bio-Rad Laboratories Inc.

      • 10.8.1. Company Overview

      • 10.8.2. Key Executives

      • 10.8.3. Company Snapshot

      • 10.8.4. Operating Business Segments

      • 10.8.5. Product Portfolio

      • 10.8.6. Business Performance

      • 10.8.7. Key Strategic Moves and Developments

    • 10.9. Mindray Medical International Limited

      • 10.9.1. Company Overview

      • 10.9.2. Key Executives

      • 10.9.3. Company Snapshot

      • 10.9.4. Operating Business Segments

      • 10.9.5. Product Portfolio

      • 10.9.6. Business Performance

      • 10.9.7. Key Strategic Moves and Developments

    • 10.10. URIT Medical Electronic Group Co. Ltd.

      • 10.10.1. Company Overview

      • 10.10.2. Key Executives

      • 10.10.3. Company Snapshot

      • 10.10.4. Operating Business Segments

      • 10.10.5. Product Portfolio

      • 10.10.6. Business Performance

      • 10.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL URINALYSIS MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL URINALYSIS MARKET FOR DIPSTICK, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL URINALYSIS MARKET FOR REAGENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL URINALYSIS MARKET FOR URINE ANALYSER, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL URINALYSIS MARKET FOR POC, BY REGION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL URINALYSIS MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL URINALYSIS MARKET FOR BIOCHEMICAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL URINALYSIS MARKET FOR SEDIMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL URINALYSIS MARKET FOR MICROSCOPIC, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL URINALYSIS MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL URINALYSIS MARKET FOR DIAGNOSIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL URINALYSIS MARKET FOR DIABETES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL URINALYSIS MARKET FOR UTI, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL URINALYSIS MARKET FOR KIDNEY DISEASE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL URINALYSIS MARKET FOR PREGNANCY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. GLOBAL URINALYSIS MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. GLOBAL URINALYSIS MARKET FOR HOSPITAL, BY REGION, 2022-2032 ($MILLION)
  • TABLE 18. GLOBAL URINALYSIS MARKET FOR RESEARCH INSTITUTE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 19. GLOBAL URINALYSIS MARKET FOR HOME, BY REGION, 2022-2032 ($MILLION)
  • TABLE 20. GLOBAL URINALYSIS MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 21. NORTH AMERICA URINALYSIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 22. NORTH AMERICA URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 23. NORTH AMERICA URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 24. NORTH AMERICA URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. NORTH AMERICA URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. U.S. URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. U.S. URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 28. U.S. URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 29. U.S. URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. CANADA URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. CANADA URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 32. CANADA URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 33. CANADA URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. MEXICO URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 35. MEXICO URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 36. MEXICO URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 37. MEXICO URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 38. EUROPE URINALYSIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 39. EUROPE URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 40. EUROPE URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 41. EUROPE URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 42. EUROPE URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. FRANCE URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 44. FRANCE URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 45. FRANCE URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 46. FRANCE URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 47. GERMANY URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 48. GERMANY URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 49. GERMANY URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. GERMANY URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. ITALY URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 52. ITALY URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 53. ITALY URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 54. ITALY URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. SPAIN URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. SPAIN URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 57. SPAIN URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 58. SPAIN URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. UK URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 60. UK URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 61. UK URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 62. UK URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 63. RUSSIA URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 64. RUSSIA URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 65. RUSSIA URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. RUSSIA URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. REST OF EUROPE URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 68. REST OF EUROPE URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 69. REST OF EUROPE URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 70. REST OF EUROPE URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. ASIA-PACIFIC URINALYSIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 72. ASIA-PACIFIC URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 73. ASIA-PACIFIC URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 74. ASIA-PACIFIC URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 75. ASIA-PACIFIC URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 76. CHINA URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 77. CHINA URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 78. CHINA URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 79. CHINA URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. JAPAN URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 81. JAPAN URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 82. JAPAN URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 83. JAPAN URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. INDIA URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 85. INDIA URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 86. INDIA URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 87. INDIA URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 88. SOUTH KOREA URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 89. SOUTH KOREA URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 90. SOUTH KOREA URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 91. SOUTH KOREA URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. AUSTRALIA URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 93. AUSTRALIA URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 94. AUSTRALIA URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 95. AUSTRALIA URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 96. THAILAND URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 97. THAILAND URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 98. THAILAND URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 99. THAILAND URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 100. MALAYSIA URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 101. MALAYSIA URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 102. MALAYSIA URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 103. MALAYSIA URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. INDONESIA URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 105. INDONESIA URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 106. INDONESIA URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 107. INDONESIA URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 108. REST OF ASIA PACIFIC URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 109. REST OF ASIA PACIFIC URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 110. REST OF ASIA PACIFIC URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 111. REST OF ASIA PACIFIC URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 112. LAMEA URINALYSIS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 113. LAMEA URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 114. LAMEA URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 115. LAMEA URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 116. LAMEA URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 117. BRAZIL URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 118. BRAZIL URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 119. BRAZIL URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 120. BRAZIL URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 121. SOUTH AFRICA URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 122. SOUTH AFRICA URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 123. SOUTH AFRICA URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 124. SOUTH AFRICA URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 125. SAUDI ARABIA URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 126. SAUDI ARABIA URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 127. SAUDI ARABIA URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 128. SAUDI ARABIA URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 129. UAE URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 130. UAE URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 131. UAE URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 132. UAE URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 133. ARGENTINA URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 134. ARGENTINA URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 135. ARGENTINA URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 136. ARGENTINA URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 137. REST OF LAMEA URINALYSIS, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 138. REST OF LAMEA URINALYSIS, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 139. REST OF LAMEA URINALYSIS, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 140. REST OF LAMEA URINALYSIS, BY END USER, 2022-2032 ($MILLION)
  • TABLE 141. ARKRAY INC.: KEY EXECUTIVES
  • TABLE 142. ARKRAY INC.: COMPANY SNAPSHOT
  • TABLE 143. ARKRAY INC.: OPERATING SEGMENTS
  • TABLE 144. ARKRAY INC.: PRODUCT PORTFOLIO
  • TABLE 145. ARKRAY INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 146. BECKMAN COULTER INC.: KEY EXECUTIVES
  • TABLE 147. BECKMAN COULTER INC.: COMPANY SNAPSHOT
  • TABLE 148. BECKMAN COULTER INC.: OPERATING SEGMENTS
  • TABLE 149. BECKMAN COULTER INC.: PRODUCT PORTFOLIO
  • TABLE 150. BECKMAN COULTER INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 151. ROCHE DIAGNOSTICS: KEY EXECUTIVES
  • TABLE 152. ROCHE DIAGNOSTICS: COMPANY SNAPSHOT
  • TABLE 153. ROCHE DIAGNOSTICS: OPERATING SEGMENTS
  • TABLE 154. ROCHE DIAGNOSTICS: PRODUCT PORTFOLIO
  • TABLE 155. ROCHE DIAGNOSTICS: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 156. SIEMENS HEALTHCARE: KEY EXECUTIVES
  • TABLE 157. SIEMENS HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 158. SIEMENS HEALTHCARE: OPERATING SEGMENTS
  • TABLE 159. SIEMENS HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 160. SIEMENS HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 161. SYSMEX CORPORATION: KEY EXECUTIVES
  • TABLE 162. SYSMEX CORPORATION: COMPANY SNAPSHOT
  • TABLE 163. SYSMEX CORPORATION: OPERATING SEGMENTS
  • TABLE 164. SYSMEX CORPORATION: PRODUCT PORTFOLIO
  • TABLE 165. SYSMEX CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 166. ELEKTRONIKA KFT: KEY EXECUTIVES
  • TABLE 167. ELEKTRONIKA KFT: COMPANY SNAPSHOT
  • TABLE 168. ELEKTRONIKA KFT: OPERATING SEGMENTS
  • TABLE 169. ELEKTRONIKA KFT: PRODUCT PORTFOLIO
  • TABLE 170. ELEKTRONIKA KFT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 171. ACON LABORATORIES INC.: KEY EXECUTIVES
  • TABLE 172. ACON LABORATORIES INC.: COMPANY SNAPSHOT
  • TABLE 173. ACON LABORATORIES INC.: OPERATING SEGMENTS
  • TABLE 174. ACON LABORATORIES INC.: PRODUCT PORTFOLIO
  • TABLE 175. ACON LABORATORIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 176. BIO-RAD LABORATORIES INC.: KEY EXECUTIVES
  • TABLE 177. BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT
  • TABLE 178. BIO-RAD LABORATORIES INC.: OPERATING SEGMENTS
  • TABLE 179. BIO-RAD LABORATORIES INC.: PRODUCT PORTFOLIO
  • TABLE 180. BIO-RAD LABORATORIES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 181. MINDRAY MEDICAL INTERNATIONAL LIMITED: KEY EXECUTIVES
  • TABLE 182. MINDRAY MEDICAL INTERNATIONAL LIMITED: COMPANY SNAPSHOT
  • TABLE 183. MINDRAY MEDICAL INTERNATIONAL LIMITED: OPERATING SEGMENTS
  • TABLE 184. MINDRAY MEDICAL INTERNATIONAL LIMITED: PRODUCT PORTFOLIO
  • TABLE 185. MINDRAY MEDICAL INTERNATIONAL LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 186. URIT MEDICAL ELECTRONIC GROUP CO. LTD.: KEY EXECUTIVES
  • TABLE 187. URIT MEDICAL ELECTRONIC GROUP CO. LTD.: COMPANY SNAPSHOT
  • TABLE 188. URIT MEDICAL ELECTRONIC GROUP CO. LTD.: OPERATING SEGMENTS
  • TABLE 189. URIT MEDICAL ELECTRONIC GROUP CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 190. URIT MEDICAL ELECTRONIC GROUP CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL URINALYSIS MARKET SEGMENTATION
  • FIGURE 2. GLOBAL URINALYSIS MARKET
  • FIGURE 3. SEGMENTATION URINALYSIS MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN URINALYSIS MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALURINALYSIS MARKET
  • FIGURE 11. URINALYSIS MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. URINALYSIS MARKET FOR DIPSTICK, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. URINALYSIS MARKET FOR REAGENT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. URINALYSIS MARKET FOR URINE ANALYSER, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. URINALYSIS MARKET FOR POC, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 16. URINALYSIS MARKET SEGMENTATION, BY BY TEST TYPE
  • FIGURE 17. URINALYSIS MARKET FOR BIOCHEMICAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. URINALYSIS MARKET FOR SEDIMENT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. URINALYSIS MARKET FOR MICROSCOPIC, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. URINALYSIS MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 21. URINALYSIS MARKET FOR DIAGNOSIS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. URINALYSIS MARKET FOR DIABETES, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. URINALYSIS MARKET FOR UTI, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. URINALYSIS MARKET FOR KIDNEY DISEASE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. URINALYSIS MARKET FOR PREGNANCY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 26. URINALYSIS MARKET SEGMENTATION, BY BY END USER
  • FIGURE 27. URINALYSIS MARKET FOR HOSPITAL, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 28. URINALYSIS MARKET FOR RESEARCH INSTITUTE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 29. URINALYSIS MARKET FOR HOME, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 30. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 31. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 32. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 33. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 34. COMPETITIVE DASHBOARD
  • FIGURE 35. COMPETITIVE HEATMAP: URINALYSIS MARKET
  • FIGURE 36. Top player positioning, 2022
  • FIGURE 37. ARKRAY INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 38. ARKRAY INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 39. ARKRAY INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 40. BECKMAN COULTER INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 41. BECKMAN COULTER INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 42. BECKMAN COULTER INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 43. ROCHE DIAGNOSTICS: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 44. ROCHE DIAGNOSTICS: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 45. ROCHE DIAGNOSTICS: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 46. SIEMENS HEALTHCARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 47. SIEMENS HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 48. SIEMENS HEALTHCARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 49. SYSMEX CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 50. SYSMEX CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 51. SYSMEX CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 52. ELEKTRONIKA KFT: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. ELEKTRONIKA KFT: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 54. ELEKTRONIKA KFT: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 55. ACON LABORATORIES INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 56. ACON LABORATORIES INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 57. ACON LABORATORIES INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 58. BIO-RAD LABORATORIES INC.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 59. BIO-RAD LABORATORIES INC.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 60. BIO-RAD LABORATORIES INC.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 61. MINDRAY MEDICAL INTERNATIONAL LIMITED: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 62. MINDRAY MEDICAL INTERNATIONAL LIMITED: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 63. MINDRAY MEDICAL INTERNATIONAL LIMITED: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 64. URIT MEDICAL ELECTRONIC GROUP CO. LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 65. URIT MEDICAL ELECTRONIC GROUP CO. LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 66. URIT MEDICAL ELECTRONIC GROUP CO. LTD.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Urinalysis Market

Start reading.
This Report and over 68,418+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers